[Research hub intro — client-authored copy pending]
Compound profiles
GLP TZ is a GIP/GLP-1 dual-receptor agonist and the first FDA-approved peptide in its class — its clinical significance rests on pairing two complementary incretin pathways in a single molecule, a mechanism now used as the reference point for newer multi-agonist peptides like retatrutide.
Stratosbiolabs Research Team
Compound profiles
"TB-500" is the commercial research-chemical name associated with Thymosin Beta-4 (Tβ4), a naturally occurring actin-sequestering protein whose mechanism operates at the level of cytoskeletal polymerization dynamics and cell motility signaling.
Stratosbiolabs Research Team
Compound profiles
Retatrutide is an investigational peptide engineered to activate three separate metabolic hormone receptors — GIP, GLP-1, and glucagon — at once, combining appetite, insulin, and energy-expenditure pathways that earlier single- and dual-agonist peptides addressed only in part.
Pep-Pedia Research Team
Compound profiles
Ipamorelin is a pentapeptide agonist at the ghrelin receptor (GHS-R1a), first characterized in 1998 as a selective secretagogue distinguished by a narrower downstream signaling profile than earlier compounds in its structural class.
Stratosbiolabs Research Team
Compound profiles
CJC-1295 without DAC — often labeled "Mod GRF (1-29)" — is a modified fragment of growth hormone-releasing hormone engineered for GHRH-receptor agonism without the albumin-binding conjugate that extends the half-life of its DAC-linked counterpart.
Stratosbiolabs Research Team
Compound profiles
BPC-157 is a synthetic 15-amino-acid peptide studied in preclinical pharmacology for its proposed interactions with nitric oxide signaling and growth-factor receptor pathways — notably, a specific high-affinity cell-surface receptor for the peptide has not been identified in the published literature.
Stratosbiolabs Research Team